Effect of down-regulating HER4 gene on migration and invasion of esophageal carcinoma cell line Eca-109

Fudan University Journal of Medical Sciences

Volumn 35, Issue 4, 2008, Pages 521-527

  Pang, Xu Guang ^a   Fan, Hong ^a   Ge, Di ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Esophageal carcinoma; HER4; Metastasis; Rna interference

Indexed keywords

EID: 49849097003     PISSN: 16728467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture[J]. Eur J Cancer, 2001 , 37 (Suppl 8):S4-S66.
2. Enzinger PC, Mayer RJ. Esophageal cancer [J]. N Engl J Med, 2003,349:2 241-2 252.
3. Chinese source
4. Normanno N, Bianco C, Strizzi L, et al. The ErbB receptors and their ligands in cancer; an overview [J]. Curr Drug Targets, 2005,6:243-257.
5. Cohen MH, Williams GA, Sridhara R, et al. United States Food and Drug Administration drug approval summary: gefitinib (ZD1839: Iressa): tablets [J]. Clin Cancer Res, 2004,10:1 212-1 218.
6. Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase II trialof gefitinib for previously treated patients with advanced non-small-cell lung cancer[J]. J Clin Oncol,2003,21:2 237-2 246.
7. Graber HU, Friess H, Kaufmann B, et al. ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer [J]. Int J Cancer, 1999,84:24-27.
8. Lee JC, Wang ST, Chow NH, et al. Investigation of the prognostic value of co-expressed erbB family members for the survival of colorectal cancer patients after curative surgery [J]. Eur J Cancer, 2002,38:1 065-1 071.
9. Abd El-Rehim DM, Finder SE, Paish CE, et al. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma [J]. Br J Cancer, 2004,91:1 532-1 542.
10. Gilmour LMR, Macleod KG, McCaig A, et al. Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer[J].Cancer Res, 2001,61:2 169-2 176.
11. Kountourakis P, Pavlakis K, Psyrri A, et al. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinoma[J]. BMC Cancer ,2006,28(6):46. [12] Starr A, Greif J, Vexier A, et al. ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy[J]. Int J Cancer, 2006,119(2):269-274.
12. Witton CJ, Reeves JR, Going JJ, et al. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer [J] J Pathol, 2003 ,200:290-297.
13. Plowman GD, Culouscou JM, Whitney GS, et al. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family[J]. Proc Natl Acad Sci USA, 1993,90:1 746-1 750.
14. Cohen BD, Green JM, Foy L, et al. HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers[J]. J Biol Chem ,1996,271 ,4 813 -4 818.
15. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis[J]. Cancer, 1993,71:1 368-1 383.
16. O-charoenrat P, Wongkajornsilp A, Rhys-Evans PH, et al. Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells[J]. Int J Cancer ,2004,111(2):174-183.
17. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen[J]. Science, 1989, 246:1 306-1 309.
18. Yen L, Benlimame N, Nie ZR, et al. Differential regulation of tumor angiogenesis by distinct ErbB homo-and heterodimers [J]. Mol Biol Cell, 2002,13(11):4 029-4 044.
19. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases : biologic activity and clinical implications [J]. J Clin Oncol, 2000,18:1 135-1 149.